Sacral neuromodulation produced efficacy and quality of life results that were superior to standard oral medication in what researchers say is the first study to compare the benefits of the two treatments in a population of less-severe overactive bladder patients.
From evidence to practice: Dr. Makarov discusses implementation science in urology
July 25th 2024“What our major contribution is, I think as urologists doing implementation science, is determining the important questions, which we are particularly well-suited to do because we're taking care of the patients,” says Danil V. Makarov, MD, MHS.